Ischemic Stroke in a Young Adult Male During Finasteride Therapy

March 2026 in “ Cureus ”

Ribal Houmani, Jad Houmani, Amira Hamou, Saad Aad, Ghassan Nabbout

finasteride androgenetic alopecia Factor V Leiden mutation thrombosis antiplatelet therapy Propecia

Studysummary In this case study, ischemic stroke occurred in a 20-year-old male taking finasteride for hair loss, with multiple genetic predispositions for thrombosis; while causality is uncertain, clinicians should exercise caution when prescribing finasteride to patients with thrombotic risk factors.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on cureus.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects

October 2023 in “Georgetown medical review”

This review found that both finasteride and dutasteride are effective for treating hair loss in men with androgenetic alopecia, with dutasteride showing higher efficacy, but noted unclear clinical significance regarding potential negative impacts on reproduction, including possible sexual dysfunction and effects on spermatogenesis.

research Two Cases of Stroke Associated with the Use of Finasteride, an Approved Drug for Male-Pattern Hair Loss in Japan

7 citations , January 2014 in “Rinshō shinkeigaku”

This report describes two cases of stroke associated with finasteride use for male-pattern hair loss, suggesting a potential link to thrombosis due to increased estrone and estradiol levels.